Doctor profile · Federal record
Dr. Pavel Buzadzhi
Acute Care Nurse Practitioner (CMS: Nurse Practitioner) · Tulsa, OK
- NPI 1790318426
- Accepts Medicare
- MIPS 93.3 / 100 · 2023
- 7 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1265 S Utica Ave
Tulsa, OK 741044243
(918) 592-0999 - Mailing address
-
9228 S Mingo RD Ste 200
Tulsa, OK 741335722
Credentials & registration
- NPI registered
- February 2020 — 6 yrs on file
- Year of graduation
- 2019 — 7 yrs since
- Specialty taxonomy
- 363LA2100X — NUCC code
- State license (1)
- Oklahoma #106598
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1790318426. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
309
Distinct HCPCS
5
Medicare allowed
$28,916
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 140 | 111 | $79 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 94 | 74 | $116 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 35 | 32 | $145 | |
G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 28 | 19 | $25 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 12 | 12 | $103 |
In context: peer comparison
Among 37 peers in this city , average services per provider: 129. This provider delivers 2.4× the peer median.Open Payments
Industry payments received
All-time total
$5,958
Transactions
136
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbott Laboratories | 29 | $2,120.04 | |
| ABIOMED | 4 | $1,433.30 | |
| AstraZeneca Pharmaceuticals LP | 13 | $399.95 | |
| Merck Sharp & Dohme LLC | 16 | $340.45 | |
| Novartis Pharmaceuticals Corporation | 21 | $249.95 | |
| United Therapeutics Corporation | 9 | $213.64 | |
| Lexicon Pharmaceuticals, Inc. | 7 | $209.55 | |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $156.81 | |
| E.R. Squibb & Sons, L.L.C. | 10 | $155.57 | |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $123.48 | |
| Novo Nordisk Inc | 1 | $113.12 | |
| Actelion Pharmaceuticals US, Inc. | 3 | $101.12 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $77.42 | |
| PFIZER INC. | 4 | $67.98 | |
| Kestra Medical Technology Services, Inc. | 2 | $58.67 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,657
Patients
624
Total drug cost
$417,594
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Entresto (Sacubitril/Valsartan) | Brand | 246 | 56 | $191,603 |
| Spironolactone | Generic | 239 | 95 | $2,351 |
| Potassium Chloride | Generic | 203 | 78 | $6,926 |
| Torsemide | Generic | 166 | 69 | $4,408 |
| Jardiance (Empagliflozin) | Brand | 127 | 42 | $100,726 |
| Metoprolol Succinate | Generic | 116 | 50 | $2,623 |
| Carvedilol | Generic | 96 | 43 | $956 |
| Bumetanide | Generic | 93 | 47 | $5,619 |
| Atorvastatin Calcium | Generic | 73 | 29 | $988 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 66 | 16 | $41,685 |
Hospital affiliations
Frequently asked questions
What is Dr. Pavel Buzadzhi's medical specialty?
Dr. Pavel Buzadzhi practices Acute Care Nurse Practitioner in Tulsa, OK.
Where does Dr. Pavel Buzadzhi practice?
Dr. Pavel Buzadzhi practices at 1265 S Utica Ave, Tulsa, OK 741044243. Office phone: 9185920999.
What is Dr. Pavel Buzadzhi's NPI?
Dr. Pavel Buzadzhi's National Provider Identifier (NPI) is 1790318426, issued by NPPES.
Does Dr. Pavel Buzadzhi accept Medicare assignment?
Yes. Dr. Pavel Buzadzhi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Pavel Buzadzhi commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99215); Established patient office or other outpatient visit (HCPCS 99215). Source: CMS Medicare Physician & Other Practitioners file.